A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma

Research output: Contribution to journalLetter

Standard

A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma. / Pratt, Guy; Yap, Christina; Oldreive, Ceri; Slade, Daniel; Bishop, Rebecca; Griffiths, Mike; Dyer, Martin J S; Fegan, Chris; Oscier, David; Pettitt, Andrew; Matutes, Estella; Devereux, Stephen; Allsup, David; Bloor, Adrian; Hillmen, Peter; Follows, George; Rule, Simon; Moss, Paul; Stankovic, Tatjana.

In: British Journal of Haematology, Vol. 182, No. 3, 08.2018, p. 429-433.

Research output: Contribution to journalLetter

Harvard

Pratt, G, Yap, C, Oldreive, C, Slade, D, Bishop, R, Griffiths, M, Dyer, MJS, Fegan, C, Oscier, D, Pettitt, A, Matutes, E, Devereux, S, Allsup, D, Bloor, A, Hillmen, P, Follows, G, Rule, S, Moss, P & Stankovic, T 2018, 'A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma', British Journal of Haematology, vol. 182, no. 3, pp. 429-433. https://doi.org/10.1111/bjh.14793

APA

Pratt, G., Yap, C., Oldreive, C., Slade, D., Bishop, R., Griffiths, M., Dyer, M. J. S., Fegan, C., Oscier, D., Pettitt, A., Matutes, E., Devereux, S., Allsup, D., Bloor, A., Hillmen, P., Follows, G., Rule, S., Moss, P., & Stankovic, T. (2018). A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma. British Journal of Haematology, 182(3), 429-433. https://doi.org/10.1111/bjh.14793

Vancouver

Author

Pratt, Guy ; Yap, Christina ; Oldreive, Ceri ; Slade, Daniel ; Bishop, Rebecca ; Griffiths, Mike ; Dyer, Martin J S ; Fegan, Chris ; Oscier, David ; Pettitt, Andrew ; Matutes, Estella ; Devereux, Stephen ; Allsup, David ; Bloor, Adrian ; Hillmen, Peter ; Follows, George ; Rule, Simon ; Moss, Paul ; Stankovic, Tatjana. / A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma. In: British Journal of Haematology. 2018 ; Vol. 182, No. 3. pp. 429-433.

Bibtex

@article{c4e32a7cb8304da69706617523100aa4,
title = "A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma",
keywords = "Letter, chronic lymphocytic leukaemia, mantle cell lymphoma, DNA damage, olaparib",
author = "Guy Pratt and Christina Yap and Ceri Oldreive and Daniel Slade and Rebecca Bishop and Mike Griffiths and Dyer, {Martin J S} and Chris Fegan and David Oscier and Andrew Pettitt and Estella Matutes and Stephen Devereux and David Allsup and Adrian Bloor and Peter Hillmen and George Follows and Simon Rule and Paul Moss and Tatjana Stankovic",
year = "2018",
month = aug
doi = "10.1111/bjh.14793",
language = "English",
volume = "182",
pages = "429--433",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley",
number = "3",

}

RIS

TY - JOUR

T1 - A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma

AU - Pratt, Guy

AU - Yap, Christina

AU - Oldreive, Ceri

AU - Slade, Daniel

AU - Bishop, Rebecca

AU - Griffiths, Mike

AU - Dyer, Martin J S

AU - Fegan, Chris

AU - Oscier, David

AU - Pettitt, Andrew

AU - Matutes, Estella

AU - Devereux, Stephen

AU - Allsup, David

AU - Bloor, Adrian

AU - Hillmen, Peter

AU - Follows, George

AU - Rule, Simon

AU - Moss, Paul

AU - Stankovic, Tatjana

PY - 2018/8

Y1 - 2018/8

KW - Letter

KW - chronic lymphocytic leukaemia

KW - mantle cell lymphoma

KW - DNA damage

KW - olaparib

U2 - 10.1111/bjh.14793

DO - 10.1111/bjh.14793

M3 - Letter

C2 - 28643365

VL - 182

SP - 429

EP - 433

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -